Premier Research

Helping life science innovators turn breakthrough science into life-changing drugs, devices, and diagnostics.

[Premier Research @premierresearch]

Clinical trials are moving faster, but speed alone isn’t enough. Stronger oversight, better integration, smarter technology, and closer collaboration all play a role in keeping execution on track. Here’s what modern trial operations require: https://t.co/mSH5Y9ZzJD

[Premier Research @premierresearch]

What if the key to improving immunotherapy is helping the immune system better “see” cancer? New research explores how changing the antigens tumors display could help turn “cold” tumors “hot” and open new treatment possibilities. https://t.co/FSiHyu2nOY

[Premier Research @premierresearch]

Women's health research is entering a chapter beyond reproductive health. A broader, lifecycle-based view is opening the door to new areas of innovation like FSIAD, PMDD, & digital health.

Here are 6 trends to watch: Shifting Priorities in Women’s Health: https://t.co/G2ZFoBI3iO

[Premier Research @premierresearch]

Advancing women’s health doesn’t happen in silos. We’ll be at the Women’s Health Innovation Summit, where collaboration across disciplines is helping shape the future of women’s health development.

See you there: https://t.co/JnywTdUmI5

#PremierResearch #WHIS

[Premier Research @premierresearch]

With highly perceptible treatment effects and structured therapeutic settings, sponsors need to think differently about how they generate and interpret evidence for #psychedelic therapies.

Our blog explores what it takes to build credible, durable data: https://t.co/8FyJy7mQ1E

[Premier Research @premierresearch]

At #MeetingOnTheMesa, Premier leaders across medical affairs, clinical development, and regulatory affairs will join discussions on advancing complex therapies.

Meet the team: https://t.co/bwyIgNaT4A

[Premier Research @premierresearch]

Watch our full webinar to learn more about planning for Accelerated Approval: https://t.co/YwJLgUCKIO

[Premier Research @premierresearch]

#AcceleratedApproval is not a shortcut around FDA’s standards for safety and efficacy. It’s a different path for establishing them, with confirmatory evidence still required.

Watch our recent webinar to learn more about how the pathway works: https://t.co/cdGmYJ5fZq

[Premier Research @premierresearch]

What’s next in oncology? Our team will be in Madrid for #ESMO26, where new data, treatment advances, and emerging science will offer a look at what’s ahead for cancer research and care. https://t.co/NrG9fuXjXq

#PremierResearch #Oncology

[Premier Research @premierresearch]

Timing is one of the most consequential decisions in marketing application readiness. Our new eBook explores how teams can identify key gaps, prioritize risk, and build a more controlled path to filing: https://t.co/a2P8Sf5LkL

#PremierResearch #RegulatoryAffairs

[Premier Research @premierresearch]

Adaptive trial designs are changing how sponsors approach early-phase #oncology studies, helping identify efficacy signals sooner and make smarter decisions.

Explore how precision medicine and adaptive designs are reshaping Phase 1 and 2 oncology trials.: https://t.co/0yBYXKUPiq

[Premier Research @premierresearch]

Dermatology development is raising the bar for efficacy, durability, safety, and meaningful patient outcomes. At #EADV2026, our team will be joining the conversations shaping what comes next.

Schedule a meeting with them: https://t.co/WPougWohHZ

#PremierResearch

[Premier Research @premierresearch]

Today’s standard of care may not be the standard an asset competes against at launch.

A strong #TargetProductProfile evolves with the evidence and the market, helping teams reassess the differentiation patients, physicians, and payers will value: https://t.co/olGkWHc2J7

[Premier Research @premierresearch]

From dose selection to study design, pharmacometrics is helping inform critical decisions across drug development. Our team will be at #ACoP2026, joining conversations around MIDD and the evolving role of quantitative science.

https://t.co/IL7G8qObO2

[Premier Research @premierresearch]

When billions are invested in bringing a drug to market, knowing when to keep going, slow down, or stop matters. Explore the key factors that can help guide development decisions: Development Programs: https://t.co/YMi8y3nFoR

#PremierResearch #CommercialStrategy

[Premier Research @premierresearch]

What a great evening in Seattle! Premier hosted a happy hour bringing together industry colleagues for great conversations and new connections. Thank you to everyone who joined us.

#PremierResearch

[Premier Research @premierresearch]

Regulatory expectations continue to evolve across global clinical development.

Nicole Stansbury will be at #ACRO2026, joining industry leaders for discussions on the issues shaping clinical research worldwide.

#PremierResearch #RegulatoryAffairs

[Premier Research @premierresearch]

Safe, quality care matters throughout a patient’s journey, especially for those with noncommunicable conditions requiring ongoing clinical care.

Gwyn Bebb shares why listening to patients, anticipating risks, and honoring their trust must remain central to scientific progress.

[Premier Research @premierresearch]

The Premier road show continues! Today, our team members are at CAR-TCR and Rare Trials Summit.

From advancing next-generation cell therapies to navigating the unique challenges of rare disease trials, there’s plenty to talk about.

#PremierResearch #RareDisease #CellTherapy

[Premier Research @premierresearch]

For Dr. Herrick, #BloodCancerAwarenessMonth is more than a moment to raise awareness. It’s personal.

She experienced firsthand how research, treatment, and dedicated physicians can change a life. We are proud to support research that brings hope to patients.

#PremierResearch